Navigation Links
TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
Date:2/1/2013

 system using our patented immunotherapy. Our products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

TNI BioTech's proprietary technology, therapies and patents include the treatment of a wide range of cancers. Their most advanced clinical program involves immunotherapy with Methionine Enkephalin (MENK) also termed Opioid Growth Factor (OGF), which has been shown to stimulate the immune system even in patients with advanced cancer.

Even though TNI BioTech considers any condition that results in altered-immune response a target for investigation, they plan to pursue additional investigations for low dose naltrexone and/or MENK as valuable candidates in the treatment of the following:

  • Autoimmune states such as Crohn's disease, multiple sclerosis and rheumatoid arthritis
  • As an adjunct in cancer patients undergoing chemotherapy, radiation treatments or surgery
  • As an adjunct to antibiotics in the treatment of a variety of infectious diseases, including patients with HIV or patients with AIDS, in combination with retroviral drug therapy

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release includes various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which represent the Company's expectations or beliefs concerning future events. Statements containing expressions such as "believes," "anticipates," "intends," or "expects," used in the Company's press releases and in Disclosure Statements and Reports filed with the Over The Counter Markets through the OTC Disclosure and News Service are intended to identify forward-looking statements. All forward-looking statements involve risks
'/>"/>

SOURCE TNI BioTech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Chief Medical Officers in Biotechs Finally Have Their Own Conference
2. BioSpace Releases 2013 Life Sciences / Biotech Employment Outlook
3. Juventas Therapeutics Hires Biotechnology Veteran Paul Resnick as Vice President of Business Development
4. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
5. Biotechnology guaranteed US$ 100 K to average Brazilian corn growers in four years, according to ABRASEM
6. Riveting Biotechnology Novel, WIRED, Becomes the #1 Technothriller on Amazon
7. 2012 Cotton Biotechnology Award Recipients
8. Ganeden Biotech® Moves Its State-Of-The-Art Lab To Its World Headquarters In Cleveland
9. Biotechnology: Global Industry Guide
10. Join Cato BioVentures and Cancer Advances at Biotech Showcase 2013 & J.P. Morgan 31st Annual Healthcare Conference
11. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... and Companies " to their offering. ... report briefly reviews basics of human genome ... applications. Current large and small sequencers are ...
(Date:6/18/2013)... Seattle, WA (PRWEB) June 18, 2013 Though ... May -- 11,000, according to the U.S. Bureau of Labor ... average increase of 24,000 per month. Most new health care ... while the hospital sector saw a loss of 6,000 jobs. ... Global outplacement consultancy firm Challenger, Gray & Christmas reported that ...
(Date:6/18/2013)... 2013 ActiGraph, a leading provider of ... global research community, announced today that Dr. Victor KR ... is the Scientific Director of the Physical Fitness Research ... of Medicine at Gama Filho University and the Chairman ... State Secretariat of Health of São Paulo State, Brazil. ...
(Date:6/17/2013)... 17, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... R. Joseph as Chief Legal Officer.  Mr. Joseph ... experience and has worked in both public and private ... (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO ) ... a general counsel and senior executive and his knowledge ...
Breaking Biology Technology:DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4
... Jan. 3 Escalon Medical Corp.,(Nasdaq Capital Market: ... 510(k) clearance from the U.S. Food and Drug,Administration ... The MASTER-VU(TM) System consists of a B-scan probe ... (via a USB cable,connection) using Sonomed,s proprietary software, ...
... Jan. 3 Cinpathogen, through its,partnership in the ... clinical diagnostic technology consulting,services to Shanghai area hospitals. ... the,Shanghai Health Study, the Center has diagnosed and ... in collaboration with area,hospitals and colleagues at Fudan ...
... KENILWORTH, N.J., Jan. 2 Schering-Plough,Corporation (NYSE: ... and Drug,Administration (FDA) has assigned priority review status ... Sugammadex is specifically designed to reverse the ... States as ZEMURON(R) (rocuronium,bromide) and vecuronium bromide. Muscle ...
Cached Biology Technology:Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System 2Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System 3Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals 2Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA 2Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA 3Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA 4
(Date:6/17/2013)... associate has received a prestigious fellowship to support his ... of malaria. , Bart Bryant, research associate in biology, ... Service Award Individual Postdoctoral Fellowship, which provides $113,000 for ... researcher to receive the award and is the only ... , Bryant, a university doctoral graduate in biology, works ...
(Date:6/17/2013)... release is available in French . ... pathology in older mice with Alzheimer,s disease can be reversed ... Institute and Hospital - The Neuro, at McGill University and ... a specific receptor in the brain of mice with advanced ... published in the Journal of Neuroinflammation in May, ...
(Date:6/15/2013)... to treat osteoporosis has now been shown to stop ... that have become resistant to current targeted therapies, according ... presented June 15, 2013, at the annual Endocrine Society ... packs a powerful one-two punch that not only prevents ... flags the estrogen receptor for destruction. , "We found ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... -- featuring beautiful or otherwise interesting images created ... now viewable online: http://www.princeton.edu/artofscience "Since ... Competition has offered breathtaking pictures, surprise, and a ... associate professor of computer science and a co-organizer ...
... season is almost upon us. For most of us, the countdown ... on the beach. However, for some of us, the focus is ... quickly shed those final five or ten pounds in order to ... challenging and food cravings can make it even more difficult. Why ...
... Kudzu, an invasive vine that is spreading across the southeastern ... increases of the pollutant surface ozone, according to a study ... Proceedings of the National Academy of Sciences . Kudzu, ... the chemicals isoprene and nitric oxide, which, when combined with ...
Cached Biology News:Art of Science 2010 online gallery launches 2The psychology of food cravings 2Invasive kudzu is major factor in surface ozone pollution, study shows 2
... of Ham's F-12 was developed for culturing ... fusion. The modification consists of doubling the ... acid. The salt concentrations have been altered ... zinc sulfate per liter, which may render ...
... is an isotonic, balanced salt solution. It is ... the storage of whole blood at refrigerator temperatures ... volume of blood is collected into a container ... The solution is placed in a refrigerator at ...
... or individual RNA sequences from high throughput synthesis ... RNAs from LC Sciences. These products provide a ... of DESIGNED sequences delivered in a microtube as ... a single verified RNA sequence. This is a ...
... Shimadzus GCMS-QP2010s Gas Chromatograph/Mass Spectrometer, utilizing ... the GCMS-QP2010 Plus, offers high throughput ... an excellent performance-to-cost ratio. Like the ... constant linear velocity for optimum separation, ...
Biology Products: